Geoditin A at sublethal doses (≤5 μg/mL) decreased melanogenesis and glycosylation of tyrosinase (TYR) in murine B16 melanoma cells in a dose-dependent, but ROS- and MITF-independent manner. The gene discussed is MITF; the disease is melanoma.